Clinical Trials Browser

Phase 3 × INDUSTRY × Low Back Pain × Clear all

NCT03031938 2021-06-25

Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies

Phase 3 Completed

4 enrolled 78 charts

Cancer Pain, Osteoarthritis, Low Back Pain

NCT02367820 2021-06-22

SUMMIT-LTS

Phase 3 Completed

638 enrolled 12 charts

Low Back Pain, Chronic Pain

NCT00904280 2009-05-19

Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy

Phase 3 Completed

Neoplasms, Pain, Low Back Pain